An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these accounts directly for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in individuals injecting substances of uncertain source.
Several professionals stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Content Removal
According to TikTok, the platform has removed problematic material and banned related hashtags and search suggestions. The organization said it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, glowing testimonials and detailed guides for preparing or injecting at home.
After minutes of joining one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.
Product Information and Costs
Within these communities, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant medical dangers”.
